| __timestamp | PTC Therapeutics, Inc. | Telix Pharmaceuticals Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 79838000 | 22622695 |
| Thursday, January 1, 2015 | 121816000 | 24863028 |
| Friday, January 1, 2016 | 117633000 | 21351001 |
| Sunday, January 1, 2017 | 4577000 | 53837297 |
| Monday, January 1, 2018 | 12670000 | 16080096 |
| Tuesday, January 1, 2019 | 12135000 | 18525736 |
| Wednesday, January 1, 2020 | 18942000 | 2024000 |
| Friday, January 1, 2021 | 32328000 | 2548000 |
| Saturday, January 1, 2022 | 44678000 | 61556000 |
| Sunday, January 1, 2023 | 65486000 | 188157000 |
Unveiling the hidden dimensions of data
In the dynamic world of biotechnology, understanding cost structures is crucial for investors and stakeholders. This chart offers a fascinating glimpse into the cost of revenue trends for Telix Pharmaceuticals Limited and PTC Therapeutics, Inc. over the past decade. From 2014 to 2023, PTC Therapeutics experienced a significant fluctuation, with costs peaking in 2015 at approximately 121 million, then dropping dramatically in 2017 to just 5 million. In contrast, Telix Pharmaceuticals showed a more consistent upward trajectory, culminating in a staggering 188 million in 2023, marking an increase of over 700% from 2014. This comparison highlights the contrasting financial strategies and market responses of these two biotech giants. As the industry continues to evolve, monitoring such trends can provide valuable insights into the operational efficiencies and strategic priorities of leading companies.
Cost Insights: Breaking Down Eli Lilly and Company and PTC Therapeutics, Inc.'s Expenses
Analyzing Cost of Revenue: Vertex Pharmaceuticals Incorporated and PTC Therapeutics, Inc.
Cost Insights: Breaking Down Regeneron Pharmaceuticals, Inc. and Telix Pharmaceuticals Limited's Expenses
Cost of Revenue Comparison: Takeda Pharmaceutical Company Limited vs Telix Pharmaceuticals Limited
Cost Insights: Breaking Down Incyte Corporation and Telix Pharmaceuticals Limited's Expenses
Cost Insights: Breaking Down Catalent, Inc. and PTC Therapeutics, Inc.'s Expenses
Analyzing Cost of Revenue: Pharming Group N.V. and Telix Pharmaceuticals Limited
Cytokinetics, Incorporated vs PTC Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Telix Pharmaceuticals Limited and Alkermes plc
Cost Insights: Breaking Down Telix Pharmaceuticals Limited and Perrigo Company plc's Expenses
Comparing Cost of Revenue Efficiency: PTC Therapeutics, Inc. vs Iovance Biotherapeutics, Inc.
Cost Insights: Breaking Down PTC Therapeutics, Inc. and Wave Life Sciences Ltd.'s Expenses